FOR LIPID MALABSORPTION
Studies show that omega-3s in monoglyceride (MAG) form are more bioavailable in our bodies than EE or TG forms as MAG omega-3s bypass the process of fatty acid breakdown and are directly absorbed in the digestive track.
Providing a MAG-rich DHA oil derived from Schizochytriumn sp algae, our MAGaid™ product is rich in MaGOmega™, offering an effective and promising delivery method that helps enhance the absorption and oral bioavailability of DHA omega-3. The formulation applies a natural enzymatic process which converts DHA into absorption-ready, pre-digested MAGs, helping consumers with inhibited lipid absorption to achieve DHA health benefits.
MAGaid™ is sold in 325 mg softgels or as a finished commercial product.
Our MAGaid™ solution is IP-protected
Improves bioavailability by delivering a high concentration of absorption-ready MAG-DHA
MAG-DHA is derived from Schizochytriumn sp algae
Schizochytriumn sp algae is Generally Recognized as Safe
A similar formulation containing MaGOmega™ sourced from fish oil was tested in cystic fibrosis (CF) patients, a health condition that leads to fat malabsorption and malnutrition. It concluded that medical foods containing MAG-DHA may help to overcome the impaired absorption of DHA in CF patients. Results showed that MAG-DHA: